CD59 and breast carcinoma: Similarly, breast carcinoma cells were more easily lysed after treatment with anti-CD59 and anti-CD55 antibodies, but a much higher degree of lysis was achieved when a mixture of anti-CD59, anti-CD55, and anti-CD46 antibodies was used (34).